Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin for Inflammation in Hemodialysis
NCT06829186Phase 2Not yet recruiting
- Sponsor
- Universidad de Guadalajara
- Start
- Mar 2025
- Primary completion
- Sep 2025
01
Overview
Phase 2, randomised, double-blind trial (2 arms), sponsored by Universidad de Guadalajara. Primary endpoints: Interleukin-6 at 3 months, Tumor Necrosis Factor-alpha at 3 months and 2 more. Planned start Mar 2025; status: not yet recruiting.
Beyond the preview
Go deeper on NCT06829186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06829186.